Estonsko - estonština - Ravimiamet

adamed pharma s.a. - risedroonhape - õhukese polümeerikattega tablett - 35mg 4tk; 35mg 2tk; 35mg 12tk

Estonsko - estonština - Ravimiamet

medochemie limited - risedroonhape - õhukese polümeerikattega tablett - 35mg 4tk; 35mg 12tk

Estonsko - estonština - Ravimiamet

biologische heilmittel heel gmbh - homöopaatilised preparaadid - tablett - 50tk

Estonsko - estonština - Ravimiamet

gedeon richter plc. - dienogest - tablett - 2mg 84tk; 2mg 28tk

Estonsko - estonština - Ravimiamet

virbac - deltametriin - kriipsulahus - 10mg 1ml 2500ml 1tk; 10mg 1ml 1000ml 1tk; 10mg 1ml 4500ml 1tk; 10mg 1ml 500ml 1tk

Estonsko - estonština - Ravimiamet

zentiva k.s. - risedroonhape - õhukese polümeerikattega tablett - 35mg 4tk; 35mg 2tk; 35mg 12tk

Estonsko - estonština - Ravimiamet

bayer ag - dienogest - tablett - 2mg 84tk

Evropská unie - estonština - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - artriit, reumatoidartriit - immunosupressandid - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Estonsko - estonština - Adama

adama - suspensioonikontsentraat - kvinmerak + metasakloor - herbitsiidid

Estonsko - estonština - Ravimiamet

lex ano uab - dienogest - tablett - 2mg 28tk